James Mitchum's most recent trade in Tenax Therapeutics Inc was a trade of 500 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 1, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tenax Therapeutics Inc | James Mitchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 500 | 500 | - | - | Stock Option (right to buy) |